M
IMEPro
K76.0 Internal Medicine
Updated March 2026

Fatty (change of) liver, not elsewhere classified

ICD-10 Code: K76.0 · Body Part: Lumbar Spine

QME Evaluation Process

Liver function tests, imaging, biopsy if indicated. Evaluate toxic exposure history for industrial causation. Chapter 6 digestive system impairment.

Typical Impairment Rating

0-15% WPI based on liver function

AMA Guides Edition

5th Edition

Common Treatments

+ Lifestyle modification
+ Weight management
+ Monitoring
+ Hepatology referral

Related Conditions

Body Part Guide

Lumbar Spine Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Fatty (change of) liver, not elsewhere classified

Find a QME Specialist

Browse QME-certified physicians who evaluate fatty (change of) liver, not elsewhere classified and related lumbar spine conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Fatty (change of) liver, not elsewhere classified (K76.0)?

Fatty (change of) liver, not elsewhere classified is an ICD-10 diagnosis code (K76.0) classified under Internal Medicine conditions. It affects the Lumbar Spine and is occasionally seen in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is K76.0 rated for impairment?

The typical whole person impairment (WPI) range for Fatty (change of) liver, not elsewhere classified is 0-15% WPI based on liver function. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for K76.0?

Liver function tests, imaging, biopsy if indicated. Evaluate toxic exposure history for industrial causation. Chapter 6 digestive system impairment.

What treatments are common for Fatty (change of) liver, not elsewhere classified?

Common treatments for Fatty (change of) liver, not elsewhere classified include Lifestyle modification, Weight management, Monitoring, Hepatology referral. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.